AN ACT CONCERNING THE RESEARCH AND DEVELOPMENT TAX CREDIT EXCHANGE RATE FOR BIOTECHNOLOGY COMPANIES.

SB 51 increases the research and development (R&D) tax credit exchange rate to 100% specifically for biotechnology companies in Connecticut. This change directly affects biotech firms by allowing them to claim the full value of eligible R&D expenses as a tax credit against state tax liability. The bill amends Section 12-217ee of the general statutes to implement this rate increase, replacing any previous lower credit rate for this industry. The policy change provides a concrete financial incentive to support biotech research and development activities within the state.